South Korea · Finance & Insurance · KRW (Millions) · Annual
Key financials
KRW|Millions
ROE
-13.04%
2025 (actual)
ROA
-8.32%
2025 (actual)
Gross Margin
-
Net Margin
-
Total Assets
₩46,393.26M
2025 (actual)
Net Income
-₩3,968.1M
2025 (actual)
Valuation
-
Stock Price
-
Historical & projected performance
KRW|Millions
Reported figures and Equlion model projections for the next 4 years.
ROE
+13.2 pt
Company
ROA
+8.4 pt
Company
Total Assets
+4.3%
Company
Net Income
+103.1%
Company
Detailed data
KRW|Millions
Key metrics
Amounts in KRW (millions); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for KMPHARMACEUTICAL Co.,Ltd.? It covers the balance sheet, income statement, cash flow and Equlion model projections.